Skip to content

Multispectral Optoacoustic Tomography (MSOT) for the evaluation of liver fibrosis, steatosis and inflammation

Multispectral Optoacoustic Tomography (MSOT) for the evaluation of liver fibrosis, steatosis and inflammation - MSOT_liver

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00014625
Enrollment
90
Registered
2018-04-19
Start date
2018-04-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K74.0 K74.6 K75.8

Interventions

Group 1: MSOT (multispectral optoacoustic tomography) will be performed once for patients with liver fibrosis/ cirrhosis. Group 2: MSOT will be performed once for patients with fatty liver, inflammati

Sponsors

Universitätsklinikum Erlangen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.) Liver cirrhosis/ fibrosis diagnosed by histology, or clinical data 2.) Steatosis of the liver diagnosed by histology or ultrasound 3.) Inflammation of the liver diagnosed by histology 4.) Age >= 18 years

Exclusion criteria

Exclusion criteria: Age < 18 years Mental retardation of the patient with restriction of general judgment and awareness Pregnancy

Design outcomes

Primary

MeasureTime frame
Comparison of MSOT (multispectral optoacoustic tomography) data for patients with liver cirrhosis/ fibrosis, steatosis, inflammation to healthy controls. MSOT is performed after study inclusion at the Department 1 of the University Hospital in Erlangen.

Secondary

MeasureTime frame
If available, comparison of the histology to the MSOT (multispectral optoacoustic tomography) data (degree of fibrosis, degree of steatosis, degree of inflammation) after the MSOT exam.

Countries

Germany

Contacts

Public ContactLukas Pfeifer

Medizinische Klinik 1 University of Erlangen-Nürnberg

Lukas.Pfeifer@uk-erlangen.de04991318545096

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026